A single administration of an iodine thyroid blocking agent is usually sufficient to protect thyroid from radioactive iodine and prevent thyroid cancer. Repeated administration of stable iodine (rKI) may be necessary during prolonged or repeated exposure to radioactive iodine. We previously showed that rKI for eight days offers protection without toxic effects in adult rats. However, the effect of rKI administration in the developing foetus is unknown, especially on brain development, although a correlation between impaired maternal thyroid status and a decrease in intelligence quotient of the progeny has been observed. This study revealed distinct gene expression profiles between the progeny of rats receiving either rKI or saline during pregnancy. To understand the implication of these differentially expressed (DE) genes, a systems biology approach was used to construct networks for each organ using three different techniques: Bayesian statistics, sPLS-DA and manual construction of a Process Descriptive (PD) network. The PD network showed DE genes from both organs participating in the same cellular processes that affect mitophagy and neuronal outgrowth. This work may help to evaluate the doctrine for using rKI in case of repetitive or prolonged exposure to radioactive particles upon nuclear accidents. During a nuclear emergency, large amounts of radioactive particles may be released and may contaminate the environment and populations. Isotopes present in the atmospheric discharges include radioactive iodine-131. To prevent health consequences, one of the main protective methods is the Iodine Thyroid Blocking (ITB) agent which aims to saturate the thyroid gland with non-radioactive iodine and thus avoiding the fixation of radioactive iodine (Wolff-Chaikoff effect) 1. However, the recent 2011 Fukushima Daiichi disaster suggested that the World Health Organization's "ITB guidelines" 2 that so far supported a single intake of 130 mg potassium iodide (KI) tablet for individuals older than 12 years, cannot adequately protect populations in case of prolonged (beyond 24 h) or repeated exposure. In such situations, a second intake of stable iodine is possible, although the "ITB guidelines" so far give no indication on how to implement such repeated administration of KI 2,3. Therefore, more knowledge about repetitive stable iodine administration is essential to prevent the side effects of repeated ITB on specific sensitive sub-populations such as pregnant women, foetusses, and elderly 3. Recently, preclinical data, obtained by our group, have showed that repeated ITB procedure with a daily administration of 1 mg/kg/day 4,5 for eight days of KI does not induce adverse outcome (AO) in adult rats 6,7. However, for higher risk groups such as pregnant women and unborn children, a negative impact may be expected, such as hypothyroidism and related CNS impairment, decrease in TSH and T 4-thyroid hormone, and change in behaviour 8-12. Repeated ITB administration for eight consecutive days in gestational rats, as a model for pregn...